JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v8i4.6542ArticleAnalysis of the Correlation Between Visceral Fat Area and Insulin Resistance in Patients with Type 2 Diabetes and Abdominal Obesityhttps://artdesignp.com/journal/JCNR/8/4/10.26689/jcnr.v8i4.6542ZhangGuohui,XuJuan,PengQiong,XuYalei,MaShaochang2024842024-04-30Objective: To analyze the correlation between visceral fat area and insulin resistance index (HOMA-IR) in patients with type 2 diabetes mellitus (T2DM) and abdominal obesity and to provide a reference for screening and related research of such patients. Methods: Two hundred patients with T2DM admitted to Guandu People’s Hospital of Kunming were included. The study was carried out from October 2022 to December 2023. The patients were divided into three groups according to different abdominal visceral fat areas (VFA): Group A (n = 65) was less than 75cm2, Group B (n = 75) was 75–100 cm2, and Group C (n = 60) was greater than 100 cm2. The subjects in the three groups were all tested for glycated hemoglobin (HbA1c), fasting insulin (FINS), and fasting blood glucose (FPG). Height and weight were measured to calculate body mass index (BMI). The HOMA-IR and TYG (fasting triglyceride and glycemic index) were also calculated. Changes in the BMI, VFA, HOMA-IR, and TYG levels were observed in the three groups. Results: The VFA, BMI, HbA1c, FPG, FINS, HOMA-IR, and TYG of the patients all increased, with a more significant increase in the BMI, FINS, HOMA-IR, and TYG levels (P < 0.01). Multiple linear stepwise regression analyses used visceral fat area (VFA) as the dependent variable. The results showed that VFA was closely related to BMI, FINS, HOMA-IR, and TYG. Conclusion: Early reduction of VFA to reduce insulin resistance may be a better treatment and effective method for T2DM, providing powerful measures and new strategies for effective blood sugar control and early prevention in the treatment of metabolic diseases.

Cui Q, Lou Q, Sun Z, et al., 2023, Relationship Between Obesity Indicators and Carotid Artery Intima-Media Thickness in Patients with Type 2 Diabetes. Chinese Journal of Diabetes, 31(12): 909–915.

Tian Y, Li J, Liu Y, 2022, Effects of Insulin Resistance and Thyroid Hormone Levels on Visceral Fat Area in Elderly Patients with Metabolic Syndrome. Hainan Medicine, 33(6): 696–699.

Wu W, Mao Y, Shi Z, et al., 2022, Clinical Study on The Correlation Between Obesity, Insulin Resistance, and Biomarker Levels in Patients with Type 2 Diabetes. Chinese Experimental Diagnostics, 26(3): 390–393.

Kim EH, Kim HK, Lee MJ, et al., 2021, Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus. Diabetes and Metabolism Journal, 46(3): 420–428.

Kuang L, Dai W, Ye J, et al., 2022, Serum 25(OH)D, ?-GGT, SUA/SCr Ratio and Obesity Body Surface Measurement Indicators, Glucose and Lipid Metabolism in Patients with Type 2 Diabetes and Metabolic Syndrome Correlation with Insulin Resistance. Advances in Modern Biomedicine, 22(14): 2753–2757.

Zhou S, Yan H, Xia X, et al., 2023, Clinical Observation of Weight Loss on Muscle Content in Patients with Type 2 Diabetes and Overweight and Obesity. Beijing Medicine, 45(11): 934–937.

Pang T, Zhang P, Lan H, et al., 2023, The Relationship Between Postpartum Visceral Fat Area and Insulin Resistance in Patients with Gestational Diabetes. Chinese Maternal and Child Health Research, 34(11): 54–60.

Lin X, Chen Z, Huang H, et al., 2022, Diabetic Kidney Disease Progression is Associated with Decreased Lower-Limb Muscle Mass and Increased Visceral Fat Area in T2DM Patients. Frontiers in Endocrinology, 13(3): 1018–1021.

Xiang X, Ye J, 2023, Relationship Between Visceral Fat Area and Cardiovascular and Cerebrovascular Complications in Patients with Type 2 Diabetes with Normal Body Mass Index. China Medical Herald, 20(33): 100–103.

Zhang P, Yu J, Wang F, et al., 2023, Relationship Between Visceral Fat Area and Glucose Metabolism in Patients with Type 2 Diabetes. Youjiang Medicine, 51(11): 995–998.

Cai J, Wang Y, Tian Y, 2021, Correlation Analysis Between Homocysteine, Visceral Fat Area, and Macrovascular Disease in Patients with Type 2 Diabetes. Clinical Medical Engineering, 28(12): 1663–1664.

Yang J, Chen N, 2023, The Relationship Between Visceral Fat Area/Leg Muscle Mass and Type 2 Diabetes in The Elderly is Complicated with Coronary Atherosclerotic Heart Disease. Shandong Medicine, 63(26): 49–51.